Understand how pharmaceutical companies collaborate to access innovation, combine capabilities and advance development using intelligence from 1,404 real-world partnering deals.
Collaboration Deals in Pharmaceuticals 2021-2026 provides comprehensive intelligence on 1,404 collaboration deals involving pharmaceutical companies and their external partners.
Collaboration is central to pharmaceutical innovation. Companies increasingly work with biotechnology companies, research organizations, technology providers and other partners to access new science, combine complementary capabilities, accelerate development and create new routes to commercialization.
These relationships can take many forms, from early research and discovery partnerships through to development, technology, manufacturing and commercialization collaborations.
The report brings this activity together in one resource, enabling users to understand who is collaborating, where partnering activity is concentrated, how agreements are structured, which companies are most active and what can be learned from disclosed financial terms and publicly available contract documents.
Rather than simply providing a list of transactions, the report combines market-wide deal analysis with agreement-structure intelligence, leading dealmaker profiles, detailed transaction records and contract-level insight where available.
It provides a practical intelligence and benchmarking resource for business development, licensing, search and evaluation, external innovation, corporate strategy, R&D strategy, alliance management and legal teams involved in pharmaceutical partnering.
This provides useful precedent intelligence for internal benchmarking, opportunity assessment and deal preparation without relying on headline values in isolation.
Identify prospective partners, comparable transactions and relevant collaboration structures.
Search and Evaluation and External Innovation teams
Understand which pharmaceutical companies are actively seeking innovation across relevant technologies, therapeutic areas and stages of development.
Biotechnology Companies Seeking Pharmaceutical Partners
Identify companies with demonstrated interest in comparable assets, technologies and research areas.
Corporate and R&D Strategy teams
Understand how pharmaceutical companies are using external collaboration to complement internal capabilities and build pipelines.
Alliance Management teams
Examine how responsibilities, governance and continuing obligations have been structured across comparable collaborations.
Competitive and Market Intelligence teams
Track collaboration activity by company, therapy area, technology and development stage to understand changing external innovation priorities.
Legal and Transaction teams
Review publicly available agreements and precedent structures to support transaction preparation and negotiation.
The briefing applies the underlying pharmaceutical collaboration intelligence to the customer's own assets, technologies or partnering objectives.
Depending on requirements, this can include relevant comparable transactions, prospective partners, competitor activity, development-stage analysis, collaboration structures, financial benchmarks, contract insights and other intelligence selected specifically for the client's situation.
Collaboration Deals in Pharmaceuticals 2021-2026 provides comprehensive intelligence on 1,404 collaboration deals involving pharmaceutical companies and their external partners.
Collaboration is central to pharmaceutical innovation. Companies increasingly work with biotechnology companies, research organizations, technology providers and other partners to access new science, combine complementary capabilities, accelerate development and create new routes to commercialization.
These relationships can take many forms, from early research and discovery partnerships through to development, technology, manufacturing and commercialization collaborations.
The report brings this activity together in one resource, enabling users to understand who is collaborating, where partnering activity is concentrated, how agreements are structured, which companies are most active and what can be learned from disclosed financial terms and publicly available contract documents.
Rather than simply providing a list of transactions, the report combines market-wide deal analysis with agreement-structure intelligence, leading dealmaker profiles, detailed transaction records and contract-level insight where available.
It provides a practical intelligence and benchmarking resource for business development, licensing, search and evaluation, external innovation, corporate strategy, R&D strategy, alliance management and legal teams involved in pharmaceutical partnering.
Understand the pharmaceutical collaboration landscape
The report analyzes collaboration dealmaking from 2021 to 2026, including:
- Trends in collaboration activity by year
- Phase of development at the time of partnering
- Industry sector
- Therapy area
- Technology type
- Most active collaboration dealmakers
- Leading transactions by disclosed value
- Reasons companies enter collaboration agreements
- How pharmaceutical collaboration strategies are evolving
Understand how collaboration agreements are structured
Collaboration agreements can encompass a wide range of research, development and commercialization relationships.Depending on the transaction and available disclosure, users can investigate areas including:
- Research and development responsibilities
- Rights granted or retained
- Intellectual property ownership and licensing
- Research funding
- Development responsibilities
- Governance and decision-making
- Exclusivity
- Geographic and territorial rights
- Regulatory responsibilities
- Manufacturing and supply
- Commercialization responsibilities
- Financial consideration
- Milestones and royalties
- Term and termination provisions
Benchmark leading transactions and disclosed financial terms
The report identifies leading pharmaceutical collaboration deals by disclosed value and provides access to available financial information associated with individual transactions.Depending on the agreement, users can investigate elements including:
- Upfront payments
- Research funding
- Development funding
- Milestone payments
- Equity investment
- Royalty arrangements
- Other disclosed financial commitments
This provides useful precedent intelligence for internal benchmarking, opportunity assessment and deal preparation without relying on headline values in isolation.
Identify leading collaboration dealmakers and prospective partners
The report identifies the Top 25 most active collaboration dealmakers and provides transaction histories that enable users to investigate their previous activity.This can help users identify:
- Pharmaceutical companies actively accessing external innovation
- Prospective collaboration partners
- Companies repeatedly active in particular therapeutic areas
- Organizations interested in specific technologies or modalities
- Dealmakers active at relevant stages of development
- Competitors pursuing similar external innovation strategies
- Relevant precedent transactions
Support search and evaluation and external innovation
Historical partnering activity can provide an important indicator of a company's external innovation priorities.The report enables users to investigate which organizations have previously:
- Partnered around particular technologies
- Entered collaborations in specific therapeutic areas
- Engaged with assets at relevant development stages
- Repeatedly worked with external biotechnology or technology companies
- Used particular collaboration structures
- Expanded into new areas through partnering
Learn from real-world collaboration contracts
Where publicly available, the report provides access to underlying contract documents for selected pharmaceutical collaborations.These agreements can provide substantially more detail than company announcements alone, enabling users to examine how partners have documented matters including:
- Scope of collaboration
- Rights granted
- Research and development obligations
- Intellectual property
- Exclusivity
- Governance
- Financial terms
- Milestones and royalties
- Manufacturing and commercialization
- Termination and continuing rights
Comprehensive pharmaceutical collaboration deal directory
The report includes a comprehensive directory of 1,404 pharmaceutical collaboration deals, providing an extensive resource for identifying relevant precedent transactions and prospective partners.Deals can be investigated by:
- Company
- Therapy area
- Technology type
- Contract availability
Who should use this report?
Business Development and Licensing teamsIdentify prospective partners, comparable transactions and relevant collaboration structures.
Search and Evaluation and External Innovation teams
Understand which pharmaceutical companies are actively seeking innovation across relevant technologies, therapeutic areas and stages of development.
Biotechnology Companies Seeking Pharmaceutical Partners
Identify companies with demonstrated interest in comparable assets, technologies and research areas.
Corporate and R&D Strategy teams
Understand how pharmaceutical companies are using external collaboration to complement internal capabilities and build pipelines.
Alliance Management teams
Examine how responsibilities, governance and continuing obligations have been structured across comparable collaborations.
Competitive and Market Intelligence teams
Track collaboration activity by company, therapy area, technology and development stage to understand changing external innovation priorities.
Legal and Transaction teams
Review publicly available agreements and precedent structures to support transaction preparation and negotiation.
Turn market-wide collaboration intelligence into company-specific insight
For qualifying customers, the analyst can also provide a Customized Executive Partnering Briefing alongside the report.The briefing applies the underlying pharmaceutical collaboration intelligence to the customer's own assets, technologies or partnering objectives.
Depending on requirements, this can include relevant comparable transactions, prospective partners, competitor activity, development-stage analysis, collaboration structures, financial benchmarks, contract insights and other intelligence selected specifically for the client's situation.
Table of Contents
Executive SummaryChapter 1 - Introduction
Chapter 2 - Trends in collaboration dealmaking
Chapter 3 - Overview of collaboration deal structure
Chapter 4 - Leading collaboration deals
Chapter 5 - Top 25 most active collaboration dealmakers
Chapter 6 - Collaboration deals including contracts directory
Deal directory
TABLE OF FIGURES
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3T Biosciences
- 4B Technologies
- 4C Biomed
- 4D Path
- 4D Pharma
- 4P-Pharma
- 9 Meters Biopharma
- 23andMe
- 48Hour Discovery
- 111
- Aachen University
- Abbisko Therapeutics
- Abbott Laboratories
- Abbvie
- AbCellera Biologics
- Abdul Latif Jameel Health
- Abilita Therapeutics
- ABL Bio
- AbSci
- AbTherx
- Access to Comprehensive Genomic Profiling Coalition
- ACEA Therapeutics
- Acepodia
- Acerand Therapeutics
- Acer Therapeutics
- Ache
- Actelion
- Actinium Pharmaceuticals
- Actuate Therapeutics
- Acumen Analytics
- Acumen Pharmaceuticals
- Adagene
- Adapsyn Bioscience
- Adaptimmune
- Adaptive Biotechnologies
- Adaptive Phage Therapeutics
- Addex Therapeutics
- Adimab
- Advancell
- Aelis Pharma
- Aequus Pharmaceuticals
- Aerami Therapeutics
- Aerie Pharmaceuticals
- AESOP Technology
- Aethon Therapeutics
- Agepha Pharma
- AgonOx
- AIBody
- AiCuris
- Aignostics
- AIkido Pharma
- AIon Labs
- Aitia
- Ajinomoto
- Akari Therapeutics
- Akeso Biopharma
- Akili Interactive Labs
- Akoya Biosciences
- AKSO Biopharmaceutical
- Alchemab
- Alchemab Therapeutics
- Alcyone Therapeutics
- Alector
- Alectos Therapeutics
- Alessa Therapeutics
- Alexion Pharmaceuticals
- Alex Therapeutics
- Alex’s Lemonade Stand Foundation
- Algen Biotechnologies
- AliveCor
- ALK-Abello
- Alliance for Regenerative Medicine
- Alloplex Biotherapeutics
- Alloy Therapeutics
- AllStripes
- Allumiqs
- Almirall
- Alnylam Pharmaceuticals
- Alpine Immune Sciences
- Alveo Technologies
- Alvogen
- ALX Oncology
- AlzeCure Pharma
- Amathus Therapeutics
- Amazon Web Services
- Ambiopharm
- American Society of Gene and Cell Therapy
- Amgen
- Amicus Therapeutics
- Amneal Pharmaceuticals
- Amoy Diagnostics
- Amphista Therapeutics
- Amplia Therapeutics
- AMRA Medical
- Amytrx Therapeutics
- AN2 Therapeutics
- Anagenex
- Angelini Pharma
- Anima Biotech
- Anji Pharma
- Anokion
- Anpac Bio-Medical Science
- Antares Therapeutics
- Antengene
- Anthropic
- Antibe Therapeutics
- Anumana
- Apellis Pharmaceuticals
- Apollomics
- Apollo Therapeutics
- Appia Bio
- Applied BioMath
- APST Research
- Aptar Pharma
- Aqemia
- Aqilion
- Aquinnah Pharmaceuticals
- Araris Biotech
- Arbor Biotechnologies
- Arcutis Biotherapeutics
- Arecor
- Arena Pharmaceuticals
- Ares Genetics
- Argenta
- Argobio
- Ariceum Therapeutics
- Arrakis Therapeutics
- Arrowhead Pharmaceuticals
- Arsenal Biosciences
- Artios Pharma
- Artiva Biotherapeutics
- Arvinas
- Arzeda
- Asahi Kasei
- Asan Medical Center
- Ascentage Pharma
- Ascidian Therapeutics
- Asieris Pharmaceuticals
- Asklepios Biopharmaceutical
- Aspect Biosystems
- AssayQuant Technologies
- Assembly Biosciences
- Astellas Pharma
- Astellas Pharma US
- Astex Pharmaceuticals
- AstraZeneca
- ATAI Life Sciences
- Atalanta Therapeutics
- Atara Biotherapeutics
- Athebio
- Atomwise
- AUM Biosciences
- Auransa
- Aurigene Discovery Technologies
- Autifony Therapeutics
- Autigen
- Avicanna
- Avidity Biosciences
- Aviko Radiopharmaceuticals
- Axcelead Drug Discovery Partners
- Axoltis Pharma
- Aytu BioPharma
- Aztiq
- BAKX Therapeutics
- Bascom Palmer Eye Institute
- Base4 Biotechnology
- Basilea Pharmaceutica
- Battelle
- Baxter International
- Bayer
- Baylor College of Medicine
- BC Cancer Agency
- Beactica
- Beam Therapeutics
- Be Biopharma
- Beckley Psytech
- Beckman Coulter
- Beiersdorf
- BeiGene
- Beijing InnoCare Pharma
- Belharra Therapeutics
- Belief BioMed
- Benchling
- BenevolentAI
- BeOne Medicines
- BerGenBio
- Berkeley Lights
- Beroni Group
- Beth Israel Deaconess Medical Center
- Better Therapeutics
- Bicycle Therapeutics
- Bielefeld University
- BigHat Biosciences
- Bill and Melinda Gates Foundation
- BillionToOne
- Bio-Sourcing
- BioAge Labs
- BioArctic AB
- biOasis Technologies
- Biocytogen
- Biogen
- BioGeometry
- BIOHM Health Inc
- BioLabs
- BioLight
- BiolineRX
- BioLinQ
- BiologIC Technologies
- Biolojic Design
- BioMap
- BioMarin Pharmaceutical
- BioMark Diagnostics
- BioMed X Innovation Center
- Biomica
- BiomX
- BiondVax
- BioNova Pharmaceuticals
- BioNTech
- Biopharmaceutical Research Company
- Biora Therapeutics
- Biorchestra
- BioTheryX
- Biotheus
- Biotools
- BioVersys
- Blacksmith Medicines
- Blackstone
- Bliss Biopharmaceutical
- Blueprint Medicines
- BlueRock Therapeutics
- Boehringer Ingelheim
- Boehringer Ingelheim Vetmedica
- Bora Pharmaceuticals
- BostonGene
- Bota Bio
- Brainomix
- Brain Research Through Advancing Innovative NeurotechnologiesInitiative
- BridgeBio Pharma
- Bridge Biotherapeutics
- BridGene Biosciences
- Brigham and Women's Hospital
- BrightInsight
- Bright Peak Therapeutics
- Brightseed
- Bristol-Myers Squibb
- Broad Institute
- Bruno Farmaceutici
- Burning Rock
- BYOMass
- Byondis
- C4 Therapeutics
- Calidi Biotherapeutics
- CAMP4 Therapeutics
- Canadian Neuromuscular Disease Registry
- Canary Speech
- CANbridge Pharmaceuticals
- CancerCare
- Cannabix Technologies
- Capsida Biotherapeutics
- Captor Therapeutics
- Caraway Therapeutics
- Cardiff Oncology
- Cardiff University
- Care Access Research
- Caribou Biosciences
- Caris Life Sciences
- Carisma Therapeutics
- Caristo Diagnostics
- Cartography Biosciences
- Cascade ProDrug
- Catalent
- Cedars-Sinai Medical Center
- Celanese
- Celcuity
- Celdara Medical
- Celeri Health
- CelerisTx
- Cellares
- Cellarity
- Cell Cure Neurosciences
- Cellectis
- Cell Mogrify
- CellOrigin Biotech
- Cellular Biomedicine
- Celmatix
- Cend Therapeutics
- Centers for Disease Control and Prevention
- Centessa Pharmaceuticals
- Centre for Addiction and Mental Health
- Centre for Commercialization of Regenerative Medicine (CCRM)
- Centre Leon Berard
- Century Therapeutics
- Cerevance
- Chai Discovery
- Charcot-Marie-Tooth Association
- Charles River Laboratories
- CHARM Therapeutics
- Chiesi Farmaceutici
- China Resources Pharmaceutical Commercial Group International Trading
- Chinook Therapeutics
- Cholesgen
- Chongqing Yao Pharmaceutical
- Chugai Pharmaceutical
- Cidara Therapeutics
- Ciitizen
- Cimeio Therapeutics
- Cipla
- Circle Pharma
- Cirqle Biomedical
- City Therapeutics
- CJ CheilJedang
- Clear Creek Bio
- Clearmind Medicine
- ClearNote Health
- Clene Nanomedicine
- Climate Amplified Disease and Epidemics
- Clinica Universidad Navarra
- Clinton Health Access Initiative
- CMG Pharmaceutical
- CMS Aesthetics
- CNAO Foundation
- CND Life Sciences
- Coalition for Epidemic Preparedness Innovations
- Code Biotherapeutics
- Code Ocean
- Codex DNA
- Cognito Therapeutics
- Cognizant
- Coherus Biosciences
- Colgate Palmolive
- Columbia University
- Combotope Therapeutics
- Complix
- ConcertAI
- Concr
- Confo Therapeutics
- Congruence Therapeutics
- Contera Pharma
- Context Therapeutics
- Coriolis Pharma Research
- COTA
- Covant Therapeutics
- COVIRIX Medical
- Coya Therapeutics
- Creyon Bio
- Croda
- CR Pharma
- CSL
- CSPC Pharmaceutical Group
- CStone Pharmaceuticals
- Cue Biopharma
- Cullgen
- Cullinan Oncology
- Culture Biosciences
- Curacle
- Curadh MTR
- Curadigm
- Cure Duchenne
- Cure Genetics
- CURE Pharmaceutical
- Curetis
- CureVac
- Cyclenium Pharma
- Cyclica
- CymaBay Therapeutics
- CytoMed Therapeutics
- CytomX Therapeutics
- CytoReason
- D-Wave Quantum
- Daewoong Pharmaceutical
- Daiichi Sankyo
- Dalriada Drug Discovery
- Dana-Farber Cancer Institute
- Danish Cancer Society Research Center
- DarioHealth
- Datos Health
- Dawn Health
- Day One Biopharmaceuticals
- DayTwo
- Debiopharm
- Decibel Therapeutics
- Decoy Therapeutics
- Deerfield Management
- Defence Therapeutics
- DelSiTech
- Delta 4
- Denali Therapeutics
- Department of Health - Abu Dhabi
- Depixus
- Dewpoint Therapeutics
- Diabeloop
- DIAN Diagnostics
- Diatech Pharmacogenetics
- Digital Medicine Society
- Disability Solutions
- DoctorsOne Healthcare Systems
- Dong-A ST
- DotBio
- DoubleRainbow Biosciences
- Dr. Denese SkinScience
- Dr. Falk Pharma
- Dr. Reddy's Laboratories
- Dragonfly Therapeutics
- Dragon Sail Pharmaceutical
- Dren Bio
- Drugs for Neglected Diseases Initiative
- Dunad Therapeutics
- Dyadic International
- Dynacure
- Dyno Therapeutics
- Earendil Labs
- Echosens
- Editas Medicine
- Eikon Therapeutics
- Eisai
- Eisai Inc
- Elaaj Bio
- Eledon Pharmaceuticals
- Elegen
- Elektrofi
- ELEO
- Elevation Oncology
- Eleven Biotherapeutics
- Eligo Bioscience
- Eli Lilly
- Elix
- Elpis Biopharmaceuticals
- Elpiscience
- Elsie Biotechnologies
- Embark Biotech
- Emmaus Life Sciences
- Emory University
- Empatica
- Enable Injections
- Enamine
- Enara Bio
- Ensoma
- Enterome Bioscience
- Entos Pharmaceuticals
- Entrada Therapeutics
- Envisagenics
- Enzychem Lifesciences
- EpicentRx
- Epilepsy Foundation (EF)
- Epitopea
- Epivax
- EQRx
- Equillium
- Eracal Therapeutics
- Erasca
- ESSA Pharma
- Essen University Hospital
- EtectRx
- eTheRNA immunotherapies
- Eunice Kennedy Shriver Institute of Child Health and Human Development
- EVA Pharma
- Evelo Biosciences
- Everads Therapy
- Eversana
- Evexta Bio
- Evidation Health
- Evinova
- Evogene
- EVOQ Therapeutics
- Evotec
- Evozyne
- EVQLV
- ExCEEd Orphan
- Exelixis
- Exicure
- Experimental Drug Development Centre
- Exscientia
- Eyenovia
- EyePoint Pharmaceuticals
- F-Star Therapeutics
- F4 Pharma
- Facio Therapies
- Fauna Bio
- Ferring Pharmaceuticals
- Filament Health
- FivepHusion
- Flagship Biosciences
- Flagship Pioneering
- Flare Therapeutics
- Flatiron Health
- Food and Drug Administration (FDA)
- Formosa Pharmaceuticals
- Fosun Pharmaceutical
- Foundation Medicine
- Fox Chase Cancer Center
- FreeMind Group
- Freenome
- Fujifilm
- FUJIFILM Cellular Dynamics
- Fujirebio Diagnostics
- Fulgent Pharma
- Fusion Pharmaceuticals
- G1 Therapeutics
- G42 Healthcare
- Gain Therapeutics
- Galapagos
- Galmed Pharmaceuticals
- Gan & Lee
- GC Biopharma
- GE Healthcare
- Geisinger Health System
- GelMEDIX
- GEMMA Biotherapeutics
- GeneCode
- Genentech
- General Proximity
- Generate Biomedicines
- Generian Pharmaceuticals
- Geneseeq
- Genesis Therapeutics
- Genethon
- Genetic Leap
- GeNeuro
- Genevant Sciences
- Genfit
- GenFleet Therapeutics
- Genialis
- Genocea Biosciences
- Genome and Company
- Genomics LTD
- Genomic Testing Cooperative
- Genprex
- GentiBio
- Genzyme
- German Heart Centre Berlin
- Gero
- Gerresheimer
- GI Innovation
- Gilead Sciences
- Gilgamesh Pharmaceuticals
- Ginkgo BioWorks
- Givaudan
- Glenmark Pharmaceuticals
- Global Antibiotic Research and Development Partnership
- Global Virus Network
- Glooko
- GlycoNet
- Glysious
- GNS Healthcare
- GO2 Foundation for Lung Cancer
- GoodRx
- Gordian Biotechnology
- Gossamer Bio
- GO Therapeutics
- GPCR Therapeutics
- Grail
- Graviton Bioscience
- Greenstone Biosciences
- Grifols
- Gritstone Bio
- Grunenthal
- GSK
- Guardant Health
- Guerbet
- Hackensack Meridian Health
- Hadassah Medical Center
- Haisco Pharmaceutical
- Halia Therapeutics
- HALO Precision Diagnostics
- Halozyme Therapeutics
- HanAll Pharmaceuticals
- HanchorBio
- Handok Pharmaceuticals
- Hangzhou Chance Pharmaceuticals
- Hangzhou Zhongmei Huadong Pharmaceutical
- Hansa Biopharma
- Happify Health
- Harbour Biomed
- Harvard Medical School
- Harvard University
- Haystack Oncology
- Healion Bio
- Healis Therapeutics
- HealthSnap
- Heartseed
- HebeCell
- Hebei Senlang Biotechnology
- Hebrew University of Jerusalem
- Helsinn Healthcare
- Helsinn Therapeutics
- Henlius Biotech
- Hillstream BioPharma
- HitGen
- HK inno.N
- Holmusk
- Holobeam Technologies
- Holobiome
- Hong Kong Science and Technology Parks
- Hookipa Pharma
- Horizon Therapeutics
- Hospital for Special Surgery
- Hoth Therapeutics
- HotSpot Therapeutics
- Hox Therapeutics
- Huadong Medicine
- Huahui Health
- Huma
- Hume Supernatural
- Hummingbird Bioscience
- Hurdle
- I-mab
- i2O Therapeutics
- IACTA Pharmaceuticals
- Iambic Therapeutics
- IASO Biotherapeutics
- IBA
- Icagen
- Icahn School of Medicine at Mount Sinai
- Ichnos Sciences
- ICL
- Iconovo
- Idorsia
- IGM Biosciences
- IgniteData
- Iktos
- Ildong Pharmaceutical
- Illumina
- Imagine Pharmaceuticals
- IMBdx
- Imcyse
- IMIDomics
- Immatics Biotechnologies
- Immunai
- ImmunoForge
- ImmunoGen
- Immunome
- Immuron
- Immusoft
- Immutep
- IMPACT Therapeutics
- Imugene
- INBRAIN Neuroelectronics
- InCarda Therapeutics
- Inceptive
- Incyte
- Indiana University
- Indivior
- InduPro Therapeutics
- Infinimmune
- Inivata
- INNERVIA Bioelectronics
- InnoCentive
- Innodem Neurosciences
- Innoplexus
- Innovative Medicines Initiative (IMI)
- Innovent Biologics
- Insilico Medicine
- InSilicoTrials
- Insitro
- InSphero
- Inspirna
- Institute for Protein Innovation
- Institute for Research in Immunology and Cancer - Commercialization of Research
- Institute of Cancer Research
- Institut Gustave Roussy
- Institut Kanser Negara
- Integral Molecular
- Interaxon
- International Diabetes Federation (IDF)
- InveniAI
- Invenio Imaging
- Invenra
- Inventia Life Science
- Inventiva
- Invetx
- InVirtuoLabs
- Invitae
- Ionis Pharmaceuticals
- Ipsen
- IQVIA
- Isomorphic Labs
- Italian Association for the Study of Pancreas
- Iterative Scopes
- Iterion Therapeutics
- ITM Isotopen Technologien
- Jackson Laboratory
- Jacobio Pharmaceuticals
- Jaguar Health
- Janssen Biotech
- Janssen Pharmaceuticals
- Janssen Pharmaceutica NV
- Janssen Research & Development
- Japan Tobacco
- Jazz Pharmaceuticals
- JCR Pharmaceuticals
- Jenner Institute
- Jiangsu Chia Tai Tianqing Pharmaceutical
- Jiangsu Hansoh Pharmaceutical
- Jiangsu Hengrui Medicine
- Jiangsu Hengrui Pharmaceuticals
- Jiangsu NHWA Pharmaceutical
- Jnana Therapeutics
- Johnson & Johnson
- Johnson & Johnson Consumer Companies
- Johnson & Johnson Innovation
- Johnson & Johnson Vision
- Jubilant Biosys
- Junshi Biosciences
- Juvena Therapeutics
- Juvenile Diabetes Research Foundation
- Kadimastem
- Kadmon Pharmaceuticals
- Kainos Medicines
- Kairos Pharma
- Kaken Pharmaceutical
- KaliVir Immunotherapeutics
- KangaBio
- Karkinos Healthcare
- Karolinska Institute
- Kelai Pharmaceuticals
- Kelonia Therapeutics
- Kelun-Biotech Biopharmaceutical
- Kenya Medical Research Institute
- Kestrel Therapeutics
- Kettering Health
- KeyBioScience
- Kings College London
- Kiniksa Pharmaceuticals
- Kinnate Biopharma
- Kira Pharmaceuticals
- Kitanihon Pharmaceutical
- Kite Pharma
- Kling Biotherapeutics
- Kodiak Sciences
- Koneksa Health
- Korea Institute of Radiological and Medical Sciences
- Koru Medical Systems
- Kowa
- Kronos Bio
- KSQ Therapeutics
- Kumquat Biosciences
- Kura Oncology
- Kvantify
- Kymera Therapeutics
- Kyowa Hakko Kirin
- kyron.bio
- Kyverna Therapeutics
- L'Oreal
- Laboratoires Thea
- Laboratorios Farmaceuticos Rovi
- Lacerta Therapeutics
- La Jolla Labs
- Landos Biopharma
- Langara College
- LaNova Medicines
- Lantern Pharma
- Lantheus Holding
- Latvian Institute of Organic Synthesis
- Launch Therapeutics
- Lavie Bio
- Lee Moffitt Cancer Center
- LegoChem Biosciences
- Leidos
- LEO Pharma
- Les Laboratoires Servier
- Leveragen
- LEXEO Therapeutics
- LG Chem
- LianBio
- LiberoThera
- Lieber Institute
- Life Edit Therapeutics
- LifeMine Therapeutics
- Life Raft Group
- Ligand Pharmaceuticals
- Lightpoint Medical
- Lineage Cell Therapeutics
- Lisata Therapeutics
- LogicBio Therapeutics
- Lonza
- Lotus Pharmaceuticals
- Loulou Foundation
- Loxo Oncology
- Lumoptik
- Lundbeck
- Lundquist Institute
- Lung Cancer Foundation of America
- Lung Cancer Initiative
- Lung Cancer Research Foundation
- LUNGevity Foundation
- Lunit
- Lycia Therapeutics
- Lyell Immunopharma
- LyGenesis
- Lygos
- Lysando
- M42
- Macomics
- Macrogenics
- Magnet Biomedicine
- MAIA Biotechnology
- Mammoth Biosciences
- Manny Pacquiao Foundation
- Marengo Therapeutics
- Marinus Pharmaceuticals
- Massachusetts General Hospital
- Massachusetts Institute of Technology
- Massachusetts Life Sciences Center
- Mass General Brigham
- Matinas Biopharma
- Matrix Medical Network
- Max-Planck
- Max Biopharma
- Maxcyte
- Mayo Clinic
- Maze Therapeutics
- MC2 Therapeutics
- McKesson
- MD Anderson Cancer Center
- MDimune
- Medac
- Medera
- Medial EarlySign
- Mediar Therapeutics
- Medichem International
- MEDiC Life Sciences
- MediGene
- MediLink Therapeutics
- Medolife Rx
- Medomie Pharma
- MedPharm
- Medtronic
- Meharry Medical College
- Meiji Seika
- Memorial Sloan Kettering Cancer Center
- Memo Therapeutics
- Menarini
- Menicon
- Merck and Co
- Merck Animal Health
- Merck KGaA
- Merck Sharpe & Dohme
- Mereo BioPharma
- Mersana Therapeutics
- Merus
- Mestag Therapeutics
- Metaba
- Metaphore Biotechnologies
- Metrion Biosciences
- Microbiome Therapeutics Innovation Group
- Microsoft
- MILA International
- Mimetas
- MiNA Therapeutics
- Mind Medicine
- MindRank AI
- Mindset Pharma
- Minovia Therapeutics
- Mirati Therapeutics
- miRecule
- Mirimus
- Miromatrix Medical
- Mirum Pharmaceuticals
- Mitobridge
- Mitsubishi Tanabe Pharma
- Mitsui
- Modag
- Moderna
- ModeX Therapeutics
- Molecular Templates
- MOMA Therapeutics
- Monash University
- Monopar Therapeutics
- Monte Rosa Therapeutics
- Morningside Ventures
- Mosanna Therapeutics
- MSD
- MyBiotics Pharma
- MyMD Pharmaceuticals
- Myotonic Dystrophy Clinical Research Network
- Myovant Sciences
- n-Lorem Foundation
- NAMUH
- Nanoform
- NaNotics
- NanoVation Therapeutics
- Nashville Biosciences
- NATA
- Natera
- National Cancer Center
- National Comprehensive Cancer Network (NCCN)
- National Eye Institute
- National Heart
- Lung and Blood Institute
- National Human Genome Research Institute
- National Institute for Innovation in Manufacturing Biopharmaceuticals
- National Institute of Allergy and Infectious Diseases
- National Institute of Arthritis and Musculoskeletal Diseases
- National Institute of Dental and Craniofacial Research (NIDCR)
- National Institute of Infectious Diseases
- National Institute of Mental Health
- National Institute of Neurological Disorders and Stroke
- National Institute of Pharmaceutical Education and Research
- National Institute on Deafness and Other Communication Disorders
- National Institutes of Health
- National Organization for Rare Disorders
- National Resilience
- Natural Sciences and Engineering Research Council of Canada
- NatureWorks
- Navigo Proteins
- Navrogen
- nCage Therapeutics
- Nektar Therapeutics
- Nemysis
- Neochromosome
- Neolaia Bio
- Neomorph
- NeoPhore
- Neotope
- Nerviano Medical Sciences
- Nestle Health Science
- NETRIS Pharma
- Neumora Therapeutics
- Neuramedy
- Neurimmune Therapeutics
- NeuroBiogen
- NeuroBo Pharmaceuticals
- Neurocrine Biosciences
- Neurodon
- NeuroSense Therapeutics
- Neutron Therapeutics
- New York Presbyterian/Columbia
- Nexelis
- Nextage Therapeutics
- NextRNA Therapeutics
- Nicox
- NiKang Therapeutics
- Nimble Therapeutics
- Nimbus Therapeutics
- NIMIUM Therapeutics
- Niowave
- Nippon Shinyaku
- NLS Pharmaceutics
- Noetik
- Noguchi Memorial Institute for Medical Research
- Nona Biosciences
- Northeastern University
- NorthStar Medical Radioisotopes
- Novadiscovery
- Novartis
- Novartis Institutes for BioMedical Research
- Novel Biologics
- Novelty Nobility
- Novome Biotechnologies
- Novo Nordisk
- NRx Pharmaceuticals
- Nucleai
- Nuclidium
- Nucs AI
- Numab
- Nuntius Therapeutics
- Nurix Therapeutics
- Nusano
- NVDIA Corporation
- NYtor
- NYU Langone Medical Center
- Oblique Therapeutics
- Obsidian Therapeutics
- Ocean Spray Cranberries
- Ochre Bio
- Odyssey Therapeutics
- Okava Pharmaceuticals
- Olema Oncology
- OliPass
- OliX Pharmaceuticals
- Omega Laboratories
- Omega Therapeutics
- OmniAb
- Omniose
- Oncidium Foundation
- Oncode Institute
- Oncodesign
- Oncoheroes Biosciences
- OncoNano Medicine
- Oncorus
- Oncternal Therapeutics
- OneThree Biotech
- Ono Pharmaceutical
- Onward Therapeutics
- OpenAI
- Open Book Extracts
- OpGen
- Opsis Therapeutics
- Optellum
- Optimi Health
- Oragenics
- Orano Med
- Orbis Medicines
- Orbit Discovery
- Oregon Health Sciences University
- Oregon Therapeutics
- Orexia Therapeutics
- Organon
- Origami Therapeutics
- OrigiMed
- Orion
- Orionis Biosciences
- Orna Therapeutics
- Oscotec
- Osivax
- OTR Therapeutics
- Otsuka
- Ottimo Pharma
- Ovid Therapeutics
- Owkin
- Oxford BioTherapeutics
- Oyster Point Pharma
- Ozette Technologies
- PACT Pharma
- Paige
- Palatin Technologies
- Palisade Bio
- Palleon Pharmaceuticals
- Pangaea Data
- Parabilis Medicines
- Paradigm
- Paraza Pharma
- Parkinson's UK
- Partner Therapeutics
- Passage Bio
- PathAI
- Pathalys Pharma
- PaxMedica
- Pearl Bio
- PEAR Therapeutics
- PECET
- PegBio
- Peijia Medical
- Peking Union Medical College
- Pennsylvania Biotechnology Center
- Pepper Bio
- PeptiDream
- PerkinElmer
- Persephone Biosciences
- Personalis
- Peter MacCallum Cancer Institute
- Pfizer
- Pfizer Canada
- PharmAbcine
- PharmaBiome
- PharmaLogic
- PharmaTher
- PharmEnable
- Pharming Group
- Phenomic AI
- Philogen
- Phio Pharmaceuticals
- PhoreMost
- PhotonPharma
- Photys Therapeutics
- Phylloceuticals
- PhysIQ
- Pieris Pharmaceuticals
- Pierre Fabre
- Pillar Biosciences
- PineTree Therapeutics
- Pioneering Medicines
- Plexium
- Plus Therapeutics
- PlusVitech
- Pneuma Systems
- POINT Biopharma
- PointClickCare Technologies
- PolarisQB
- PoloMar Health
- Population Health Partners
- Porton Pharma Solutions
- Poseida Therapeutics
- PostEra
- Pragma Bio
- Praxis Precision Medicines
- Precision BioSciences
- PrecisionLife
- Predicine
- Pregene Biopharma
- Prellis Biologics
- Pressure BioSciences
- Prevail Therapeutics
- Prime Medicine
- PRISM BioLab
- ProBioGen
- ProEn Therapeutics
- Profluent Bio
- ProFound Therapeutics
- Progenetics
- Prokaryotics
- Prolytix
- Promises Innovative Recovery Center
- Prophase Labs
- ProQR Therapeutics
- Protagonist Therapeutics
- Proteros biostructures
- Prothena
- Proxygen
- PTC Therapeutics
- Puma Biotechnology
- QED Therapeutics
- QIAGEN
- Qilu Pharmaceutical
- Qinotto
- Quanterix
- QuantumCell
- Quebec Heart and Lung Institute
- Quell Therapeutics
- Quotient Therapeutics
- QurAlis
- Quris-AI
- Ractigen Therapeutics
- Radionetics Oncology
- Radiopharm Theranostics
- Rafa Laboratories
- Rakuten Medical
- Rallybio
- Rani Therapeutics
- Rapport Therapeutics
- Ratio Therapeutics
- RayzeBio
- Recludix Pharma
- Rectify Pharmaceuticals
- Recursion
- Redx Pharma
- Regeneron Genetics Center
- Regeneron Pharmaceuticals
- Regenxbio
- Regional Cancer Institute of Montpellier
- Regor Therapeutics
- Relation Therapeutics
- Relief Therapeutics
- Remedium Bio
- Remepy
- Remix Therapeutics
- ReNAgade Therapeutics
- Renexxion
- RenovoRx
- Repare Therapeutics
- Repertoire Immune Medicines
- Replicate Bioscience
- RespireRx Pharmaceuticals
- reViral
- ReviR Therapeutics
- ReVision Optics
- Revision Skincare
- Revitope Oncology
- Revive Therapeutics
- RevolKa
- Revolution Medicines
- Revvity
- Reyon Pharmaceuticals
- Rgenta Therapeutics
- RheaVita
- Ribometrix
- Ripple Therapeutics
- Roche
- Roche Diagnostics
- Rohto Pharmaceutical
- Rondo Therapeutics
- Roswell Biotechnologies
- Roswell Park Cancer Institute
- Royalty Pharma
- RS BioTherapeutics
- Rubedo Life Sciences
- RVL Pharmaceuticals
- Ryerson University
- Ryvu Therapeutics
- Saama
- Sail Biomedicines
- Salarius Pharmaceuticals
- Salipro Biotech
- Samsung Biologics
- Samyang Biopharmaceuticals
- Sandoz
- SanegeneBio
- Sanguina
- Sanofi
- Sanofi-Pasteur
- Santen Pharmaceutical
- Sanyou Biopharmaceuticals
- Sapien Biosciences
- Sarah Cannon Research Institute
- Sarepta Therapeutics
- Sato Pharmaceutical
- Saturnus Bio
- Scenic Biotech
- Schrodinger
- SciBase
- SciClone Pharmaceuticals
- Science 37
- Scilex Holding
- SciNeuro Pharmaceuticals
- Scipher Medicine
- SciSparc
- Sciwind Biosciences
- Scorpion Therapeutics
- Scribe Therapeutics
- Scripps Research Institute
- Scriptr Global
- Seagen
- Seamless Therapeutics
- Sean M Healey & AMG Center for ALS
- Seattle Genetics
- Secarna Pharmaceuticals
- Second Genome
- Sedec Therapeutics
- Seed Therapeutics
- Seelos Therapeutics
- Selagine
- SelectImmune Pharma
- SemaThera
- Senju Pharmaceutical
- Sentynl Therapeutics
- Septerna
- Sequence Bio
- Sequential Skin
- SeraNovo
- Serina Therapeutics
- Sermonix Pharmaceutical
- Sernova
- Serotiny
- Servatus Biopharmaceuticals
- Shanghai Argo Biopharmaceutical
- Shanghai Institute of Materia Medica
- Shanghai Medicilon
- Shape Therapeutics
- Shasqi
- Shattuck Labs
- Sheba Medical Center
- Shepherd Therapeutics
- Shionogi
- Shoreline Biosciences
- Sibylla Biotech
- SIGA Technologies
- Sigilon Therapeutics
- Sigyn Therapeutics
- Silence Therapeutics
- Simcere Pharmaceutical
- Simulations Plus
- Singapore Eye Research Institute (SERI)
- Singapore General Hospital
- Singapore Sengkang General Hospital
- Singlera Genomics
- Singular Genomics Systems
- Sino Biopharmaceutical
- Sinopia Biosciences
- Sinorda Biomedicine
- Sirenas
- Sirion Biotech
- Sironax
- SIRS Therapeutics
- SiteOne Therapeutics
- SK Biopharmaceuticals
- Skyhawk Therapeutics
- Snowflake
- Sohm
- Soleno Therapeutics
- Sonnet BioTherapeutics
- Sonoma BioTherapeutics
- Sony
- SOPHiA Genetics
- Sosei
- Sosei Heptares
- Spanish National Research Council
- Spark Therapeutics
- SpineThera
- Spiral Therapeutics
- SpringWorks Therapeutics
- SRI International
- Stanford University
- Stanford University School of Medicine
- Starpharma
- Statera Biopharma
- Step Pharma
- Stereotaxis
- Stevanato
- Storm Therapeutics
- Strand Life Sciences
- Subtle Medical
- Sumitomo Chemical Company
- Sumitomo Dainippon Pharma
- Sumitomo Mitsui Banking Corporation
- Sumitomo Pharmaceuticals
- Sumitovant Biopharma
- Summit Therapeutics
- Sunovion Pharmaceuticals
- Sun Pharma Advanced Research Company
- Sunshine Biopharma
- Surrozen
- Sutro Biopharma
- Suzhou Ribo Life Sciences
- Suzhou Siran Biotechnology
- Swiss Institute of Bioinformatics (SIB)
- Swiss Rockets
- Syapse
- Sygnature Discovery
- SylamoreBio
- Symvivo
- Syndax Pharmaceuticals
- Syneos Health
- Synthekine
- SyntheX
- Sysmex
- Sysnav Healthcare
- Systimmune
- TAE Life Sciences
- Tahoe Therapeutics
- Taiho
- Taisho Pharmaceutical
- Takeda Pharmaceutical
- Tallac Therapeutics
- TALLC
- TargetGene Biotechnologies
- Tarveda Therapeutics
- Tavotek Biotherapeutics
- Tavros Therapeutics
- Taysha Gene Therapies
- Technomark Life Sciences
- Tegmine Therapeutics
- Tel Aviv University
- TeleVet
- Telix Pharmaceuticals
- Tella
- Telomir Pharmaceuticals
- Tempest Therapeutics
- Tempus
- Ten63 Therapeutics
- Tenacia Biotechnology
- Tenaya Therapeutics
- TenNor Therapeutics
- Tentarix Biotherapeutics
- Terray Therapeutics
- Terumo Blood and Cell Technologies
- Tetra Pharm Technologies
- TetraScience
- Teva Pharmaceutical Industries
- Tevard Biosciences
- Texas Biomedical Research Institute
- The Access to Advanced Health Insitute (AAHI)
- The Jackson Laboratory
- The New York Stem Cell Foundation
- Theralase
- TheraPanacea
- Thermo Fisher Scientific
- ThinkingNodeLife
- Thoeris
- Thorne HealthTech
- Tissue Dynamics
- TiumBio
- TONIX Pharmaceuticals
- Totus Medicines
- TransCode Therapeutics
- Transgene
- TransThera
- TreeFrog Therapeutics
- Treehill Partners
- Treventis
- TRexBio
- TrialSpark
- Triastek
- Trigone Pharma
- TriSalus Life Sciences
- TRx Biosciences
- TSB Therapeutics
- TScan Therapeutics
- TTC
- Tubulis
- Turbine
- Twist Bioscience
- Ubie
- Ubix Therapeutics
- UCB
- UK Biobank
- Ultragenyx Pharmaceuticals
- Umoja Biopharma
- Undisclosed Company
- Uneedle
- Unilever
- UniQuest
- Universal Display
- Universe Pharmaceuticals
- University College London
- University Gottingen
- University Health Network
- University Libre of Brussels
- University Medical Center Utrecht
- University of Arizona
- University of Barcelona
- University of British Columbia
- University of California
- Davis
- University of California
- San Diego
- University of California Berkeley
- University of California Los Angeles
- University of California San Francisco
- University of Colorado
- University of Georgia
- University of Health Sciences Antigua
- University of Helsinki
- University of Montreal
- University of Oxford
- University of Pennsylvania
- University of Texas Health SCience Center at San Antonio
- University of Tsukuba
- University of Ulm
- University of Washington
- Unlearn
- Unnatural Products
- Unravel Biosciences
- UPL
- Uppthera
- UroGen Pharma
- UroViu
- US Army Medical Research and Material Command
- US Oncology Research
- Usynova Pharmaceuticals
- Valence Discovery
- Vall d’Hebron Research Institute
- Valo Health
- Vanda Pharmaceuticals
- Vanderbilt University
- VantAI
- Variant Bio
- VaxEquity
- Vect-Horus
- Vector Institute
- Veeva Systems
- VenatoRx
- Verana Health
- Verantos
- Veraxa Biotech
- Verge Genomics
- Verily
- VerImmune
- Vernalis
- Vertex Pharmaceuticals
- Verve Therapeutics
- Vestibular Disorders Association
- Vetigenics
- ViaNautis Bio
- Viatris
- Vibliome Therapeutics
- Vicore Pharma
- ViGeneron
- Vincere Biosciences
- Vipergen
- Vir Biotechnology
- Virginia Tech
- Visiopharm
- Visus Therapeutics
- Vitruvias Therapeutics
- Vivani Medical
- VivaVision Biotech
- Vivera Pharmaceuticals
- Vividion Therapeutics
- Vivtex
- Volastra Therapeutics
- Vor Biopharma
- Voro Therapeutics
- Voyager Therapeutics
- Vuja De Sciences
- Waiv
- WaVe Lifesciences
- WAVE Life Sciences
- Wayfinder Biosciences
- Weatherden
- WeComput
- Weill Cornell Medical College
- Wellcome Trust
- Werewolf Therapeutics
- West Pharmaceutical Services
- Whitehawk Therapeutics
- WuXi Biologics
- WuXi XDC
- Wyss Institute
- X-chem
- Xcellon Biologics
- Xencor
- Xenon Pharmaceuticals
- XERIS Pharmaceuticals
- Xilio Therapeutics
- XtalPi
- Xyphos Biosciences
- Yale University
- YASKAWA Electric
- Yingli Pharma
- Yissum Research Development
- Yiviva
- ZAI Laboratory
- Zealand Pharma
- Zedira
- Zenas BioPharma
- Zentalis Pharmaceuticals
- Zerion Pharma
- Zifo
- Zogenix
- Zonsen PepLib Biotech
- Zumutor Biologics
Methodology
- The publisher reports provide insight into the trends and terms of partnering deals in the global life sciences sector.
- The publisher reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.
- The publisher analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.
- The publisher reports source deal data from our proprietary deals and alliances database. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal.
- The data in the deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.
The publisher provides comprehensive coverage of the following partnering or deal types:
- Asset purchase
- Assignment
- Co-development
- Co-market
- Co-promotion
- Collaborative R&D
- Contract service
- CRADA
- Cross-licensing
- Development
- Distribution
- Equity purchase
- Evaluation
- Grant
- Joint venture
- Licensing
- Loan
- Manufacturing
- Marketing
- Option
- Promotion
- Research
- Royalty financing
- Settlement
- Spin out
- Sub license
- Supply
- Termination
- Warrant
Every deal record is fully categorized and includes the following data, where available:
- Industry sector
- Therapy areas
- Technology type
- Deal components
- Financial terms
- Stage of development
- Exclusivity
- Asset type
- Geographic focus
- Excluded geography
- Company press release
- SEC filing data including contract document
All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.
LOADING...
